Citadel Advisors’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$395K Buy
+233,946
New +$415K ﹤0.01% 9843
2025
Q4
Sell
-331,155
Closed -$483K 12786
2025
Q3
$543K Buy
331,155
+197,129
+147% +$219K ﹤0.01% 8933
2025
Q2
$98K Buy
+134,026
New +$116K ﹤0.01% 11364
2024
Q4
Sell
-2,857,208
Closed -$3.21M 14590
2024
Q3
$2.97M Buy
2,857,208
+13,760
+0.5% +$18.9K ﹤0.01% 4798
2024
Q2
$4.92M Buy
2,843,448
+100,821
+4% +$203K ﹤0.01% 3765
2024
Q1
$6.55M Buy
2,742,627
+754,730
+38% +$1.86M ﹤0.01% 3545
2023
Q4
$6.62M Sell
1,987,897
-671,820
-25% -$1.8M ﹤0.01% 3413
2023
Q3
$9.95M Sell
2,659,717
-3,320,003
-56% -$15.3M ﹤0.01% 2696
2023
Q2
$25.5M Buy
5,979,720
+4,482,817
+299% +$26.4M 0.01% 1636
2023
Q1
$10.2M Buy
1,496,903
+183,560
+14% +$1.42M ﹤0.01% 2792
2022
Q4
$10.4M Buy
1,313,343
+1,123,781
+593% +$8.65M ﹤0.01% 2781
2022
Q3
$1.82M Buy
+189,562
New +$1.92M ﹤0.01% 5763
2022
Q2
Sell
-125,938
Closed -$1.63M 12974
2022
Q1
$1.63M Buy
125,938
+51,797
+70% +$659K ﹤0.01% 6552
2021
Q4
$1.18M Sell
74,141
-116,283
-61% -$2.03M ﹤0.01% 7535
2021
Q3
$3.06M Buy
190,424
+174,046
+1,063% +$2.55M ﹤0.01% 5314
2021
Q2
$227K Sell
16,378
-407,421
-96% -$5.77M ﹤0.01% 11884
2021
Q1
$6.19M Buy
423,799
+203,809
+93% +$3.46M ﹤0.01% 3817
2020
Q4
$3.82M Sell
219,990
-46,276
-17% -$824K ﹤0.01% 4157
2020
Q3
$4.88M Buy
266,266
+91,608
+52% +$1.7M ﹤0.01% 3194
2020
Q2
$3.12M Sell
174,658
-149,170
-46% -$2.52M ﹤0.01% 3788
2020
Q1
$5.25M Buy
323,828
+55,172
+21% +$1.02M ﹤0.01% 2637
2019
Q4
$4.84M Sell
268,656
-405,762
-60% -$7.48M ﹤0.01% 3123
2019
Q3
$13.7M Buy
674,418
+172,187
+34% +$3.44M 0.01% 1870
2019
Q2
$11.1M Sell
502,231
-2,009,751
-80% -$34.9M 0.01% 2063
2019
Q1
$34.3M Buy
2,511,982
+313,172
+14% +$4.18M 0.02% 924
2018
Q4
$19.9M Buy
2,198,810
+266,409
+14% +$3.08M 0.01% 1240
2018
Q3
$31.9M Sell
1,932,401
-176,550
-8% -$3.13M 0.01% 1041
2018
Q2
$29.5M Buy
2,108,951
+402,929
+24% +$5.77M 0.01% 1002
2018
Q1
$18.9M Sell
1,706,022
-66,219
-4% -$724K 0.01% 1170
2017
Q4
$15.6M Buy
1,772,241
+1,579,582
+820% +$16.9M 0.01% 1342
2017
Q3
$2.57M Sell
192,659
-40,407
-17% -$535K ﹤0.01% 3108
2017
Q2
$3.34M Buy
233,066
+88,399
+61% +$1.7M ﹤0.01% 2549
2017
Q1
$3.06M Sell
144,667
-64,945
-31% -$1.6M ﹤0.01% 2557
2016
Q4
$5.9M Buy
209,612
+90,381
+76% +$2.53M 0.01% 1814
2016
Q3
$3.19M Sell
119,231
-556,501
-82% -$15.2M ﹤0.01% 2437
2016
Q2
$11.4M Buy
+675,732
New +$12.7M 0.01% 1145
2015
Q3
Sell
-7,322
Closed -$212K 8895
2015
Q2
$212K Sell
7,322
-7,188
-50% -$182K ﹤0.01% 6238
2015
Q1
$444K Buy
+14,510
New +$375K ﹤0.01% 5079

Other funds holding CHRS